Answer
It alerts healthcare professionals that you receive checkpoint immunotherapy and may develop immune-related reactions requiring prompt assessment, even after treatment ends.
Sources for this answer
- Opdualag 240 mg/80 mg concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.